Dr. Helen Irving received her BAgSc and PhD from The University of Melbourne, Australia. She conducted post-doctoral work at Vanderbilt University (USA) and The University of Kentucky (USA) before returning to Australia to take up an ARC Post-Doctoral Fellowship at La Trobe University. She is a Professor of Biomedical Sciences and is a member of the La Trobe Institute for Molecular Sciences (LIMS) at La Trobe University. Her research focuses on understanding inflammatory signals at the molecular level to develop new and improved approaches to managing inflammatory conditions.